CytoSorbents, Inc.
USPTO PatentsView assignee record - 25 granted patents across 13 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus).
The verdict
According to USPTO PatentsView, Cytosorbents ranks #11,982 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 13 technology areas.
- #11,982
- of 49,997 US assignees by volume
- Top 37%
- by Innovation Score (39.9/100)
- 18.7
- avg claims per patent
- +88%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R11982 · US Corporation #11,982 · 25 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 25 grants
- UPPER-Q #11,982/49,997
- PHOTO-FINISH Consort Medical
- CPC-FOCUS B01J · 13 areas
- INNOV-THIN 39.9/100
- CLAIMS-RICH 18.7 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +88% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Consort Medical PLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Cytosorbents’s 39.9 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Cytosorbents
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Universiteit… · near
Universiteit… · near
40 score
- CytoSorbents · this assignee
CytoSorbents · this assignee
40 score
- Pelican Imaging · near
Pelican Imaging · near
40 score
- Shenzhen Jingtai… · near
Shenzhen Jingtai… · near
40 score
- Universiti Putra… · near
Universiti Putra… · near
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Cytosorbents's Innovation Score is 39.9/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Cytosorbents?
Each dot is one of Cytosorbents’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cytosorbents’s own 18.7 claims/patent is ABOVE the 17.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Cytosorbents's grants concentrate
CytoSorbents, Inc. is a focused PatentsView assignee: 13 CPC subclasses with 84% of grants classified under B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus). Peak complete grant year is 2021 (8 grants) versus a trough of 2 in 2017. By volume, Cytosorbents sits between Consort Medical PLC and Dong-a University Research Foundation FOR Industry-academy Cooperation.
Cytosorbents's three-year grant acceleration
CytoSorbents, Inc. shows 7 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at CytoSorbents's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Consort Medical
Consort Medical PLC
25 patents
- Continental Advan…
Continental Advanced Lidar Solutions US, Inc.
25 patents
- Cree Fayetteville
Cree Fayetteville, Inc.
25 patents
- Croda
Croda, Inc.
25 patents
- Dana TM4
Dana TM4 Inc.
25 patents
- DEB IP
DEB IP Limited
25 patents
- Deep Render
Deep Render Ltd.
25 patents
- Dong-a University…
Dong-a University Research Foundation FOR Industry-academy Cooperation
25 patents
- Cytosorbents ◀
CytoSorbents, Inc.
25 patents
What this shows CytoSorbents holds 25 patents at rank #11,982, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near CytoSorbents
By rank, the assignees closest to #11,982 in granted patent volume.
- Consort Medical PLC #11,978 · 25 patents
- Continental Advanced Lidar Solutions US, Inc. #11,979 · 25 patents
- Cree Fayetteville, Inc. #11,980 · 25 patents
- Croda, Inc. #11,981 · 25 patents
- Dana TM4 Inc. #11,983 · 25 patents
- DEB IP Limited #11,984 · 25 patents
- Deep Render Ltd. #11,985 · 25 patents
- Dong-a University Research Foundation FOR Industry-academy Cooperation #11,986 · 25 patents
Leaders in B01J (Chemical OR Physical Processes)
Other assignees with the most granted patents in CytoSorbents's primary technology class.
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for CytoSorbents, neither rank-band nor same-CPC leaders (those blocks stay above). In B01J (Chemical OR Physical Processes), CytoSorbents ranks #214 of 2,755 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Cytosorbents's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 37% higher than 63% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 8.0% |
| 2018 | 4 | 16.0% |
| 2019 | 2 | 8.0% |
| 2021 | 8 | 32.0% |
| 2023 | 4 | 16.0% |
| 2024 | 3 | 12.0% |
| 2025partial year | 2 | 8.0% |
Which technologies does CytoSorbents, Inc. patent most?
Top 13 of 13 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
CytoSorbents, Inc.'s patent record in context - here's where to go next.
- CytoSorbents, Inc.'s lead technology class is B01J (Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus), 84% of its portfolio - see every assignee active in that class. Explore B01J
- Ranked #11,982 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare CytoSorbents, Inc. against Consort Medical PLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.